We offer a range of certified educational offerings for health care professionals. Stay tuned for more offerings. See the educational offerings we have developed below.

Current educational offerings:

New CE/CME/CPE Activity with Opportunity for Hands-on Training: Oncolytic Therapy for Melanoma: An APP-focused Educational Curriculum

Oncolytic therapy, introduced a decade ago, is gaining momentum as a promising treatment for melanoma. Advanced practice providers play a key role in implementing therapies like intralesional injections and require education, skill development, and credentialing support as they adopt oncolytic virotherapy. This APSHO-endorsed curriculum offers didactic content, instructional videos, and future hands-on training opportunities to support the expanded use of oncolytic therapies in clinical practice.

A SPECIAL TRAINING OPPORTUNITY!

Oncolytic therapy was first introduced in the field of oncology a decade ago. Recently, advancements have been made in oncolytic therapy, with the promise of potentially transforming the melanoma treatment landscape. In these two 1.5-hour JADPRO Live classes on October 23, 2025, participants will have the opportunity to gain hands-on training experience in injecting different types of melanoma lesions. This training opportunity has been designed to complement the above activity, Oncolytic Therapy for Melanoma: An APP-focused Educational Curriculum.

Are you interested in participating in this exclusive training opportunity? If you are interested in the care of patients with melanoma and are planning to attend JADPRO Live 2025, please fill out this interest form. We will contact you individually about availability for these exclusive sessions.

Past educational offerings:

New interactive CME/CE activity! Stage IV Melanoma: Strategies to Support Shared Decision Making

(No Longer Available for Credit)

With an expanded array of therapeutic options for Stage IV melanoma, clinicians must grapple with increased complexity for decision making. This multimedia, interactive activity, Stage IV Melanoma: Strategies to Support Shared Decision Making  uses cases to illustrate state-of-the art management of Stage IV melanoma. The activity also illustrates how to use the AIM at Melanoma Stage IV melanoma decision-making support tool Stage IV melanoma decision-making support tool and Patient Action Plans to support shared decision making. The esteemed faculty, Drs Anna Pavlick and Sunandana Chandra, also illustrate effective communication strategies and multidisciplinary approaches to provide streamlined care and consistent education and patient engagement across the oncology care team.

CME/CE on interdisciplinary care for management of complex irAEs.

JCO Oncology Practice (JCO OP) CME/CE/CPE supplement using cases to illustrate optimal interdisciplinary management of immune-related adverse events, Immuno-Oncology Essentials: Applications in Clinical Scenarios. (No Longer Available for Credit)

A JADPRO CE supplement on the management of immune-related adverse events, Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events.(No Longer Available for Credit)

Melanoma Therapeutics and Side-Effect Management: Making a Difference From the Outset (No Longer Available for Credit)

Click here to visit CancerCE.org, learn more, and view the complete accreditation information.